Effect of antiamyloid-β drugs on Alzheimer’s disease: study protocol for a systematic review and meta-analysis
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease with a complex aetiology involving multiple targets and pathways. With the continuous growth of the ageing population, the burden of AD is increasing year by year. However, there has not been new drug approved for over a decade. In...
| Published in: | BMJ Open |
|---|---|
| Main Authors: | Diyang Lyu, Yuqing Shi, Xuanxin Lyu |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-05-01
|
| Online Access: | https://bmjopen.bmj.com/content/11/5/e048453.full |
Similar Items
Resting-state functional reorganisation in Alzheimer’s disease and amnestic mild cognitive impairment: protocol for a systematic review and meta-analysis
by: Diyang Lyu, et al.
Published: (2021-10-01)
by: Diyang Lyu, et al.
Published: (2021-10-01)
Antiamyloid therapies for Alzheimer's disease: an experts' dialogue on facts and controversies
by: Paulo Caramelli
Published: (2025-05-01)
by: Paulo Caramelli
Published: (2025-05-01)
The Comparative Efficacy of Anti-Amyloid and Non-Antiamyloid Drugs for Treatment of Alzheimer’s Disease: A Network Meta-Analysis
by: Norah Htet Htet, et al.
Published: (2023-12-01)
by: Norah Htet Htet, et al.
Published: (2023-12-01)
Clinical Benefits and Risks of Antiamyloid Antibodies in Sporadic Alzheimer Disease: Systematic Review and Network Meta-Analysis With a Web Application
by: Danko Jeremic, et al.
Published: (2025-04-01)
by: Danko Jeremic, et al.
Published: (2025-04-01)
Dendrimers as Antiamyloid Agents
by: Svetlana A. Sorokina, et al.
Published: (2022-03-01)
by: Svetlana A. Sorokina, et al.
Published: (2022-03-01)
Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer's disease: patient outcomes, healthcare costs, and drug development
by: Rouen Brockmann, et al.
Published: (2023-04-01)
by: Rouen Brockmann, et al.
Published: (2023-04-01)
Design, Synthesis, and Neuroprotective Activity of Phenoxyindole Derivatives on Antiamyloid Beta (Aβ) Aggregation, Antiacetylcholinesterase, and Antioxidant Activities
by: Somjate Laivut, et al.
Published: (2023-02-01)
by: Somjate Laivut, et al.
Published: (2023-02-01)
Dual-Functional Antioxidant and Antiamyloid Cerium Oxide Nanoparticles Fabricated by Controlled Synthesis in Water-Alcohol Solutions
by: Katarina Siposova, et al.
Published: (2022-04-01)
by: Katarina Siposova, et al.
Published: (2022-04-01)
Amyloid‐β PET in Alzheimer's disease: A systematic review and Bayesian meta‐analysis
by: Dan Ruan, et al.
Published: (2023-01-01)
by: Dan Ruan, et al.
Published: (2023-01-01)
Facile Synthesis of Multifunctional Carbon Dots Derived from Camel Milk for Mn7+ Sensing and Antiamyloid and Anticancer Activities
by: Rahul Kumar, et al.
Published: (2023-09-01)
by: Rahul Kumar, et al.
Published: (2023-09-01)
Efficacy of cognitive enhancers for Alzheimer’s disease: protocol for a systematic review and network meta-analysis
by: Tricco Andrea C, et al.
Published: (2012-06-01)
by: Tricco Andrea C, et al.
Published: (2012-06-01)
Virtual reality as an adjunct to pulmonary rehabilitation of patients with chronic obstructive pulmonary disease: a protocol for systematic review and meta-analysis
by: Yi Li, et al.
Published: (2023-12-01)
by: Yi Li, et al.
Published: (2023-12-01)
Relationship between adverse childhood experiences and Alzheimer’s disease: a systematic review and meta-analysis protocol
by: Julie A Pasco, et al.
Published: (2021-08-01)
by: Julie A Pasco, et al.
Published: (2021-08-01)
Auditory electrophysiological assessments of Alzheimer’s disease and preclinical stages: protocol for a systematic review and meta-analysis
by: Dona M P Jayakody, et al.
Published: (2020-07-01)
by: Dona M P Jayakody, et al.
Published: (2020-07-01)
Cerebrospinal fluid β-amyloid1-42 levels in the differential diagnosis of Alzheimer's disease--systematic review and meta-analysis.
by: Jin-A Mo, et al.
Published: (2015-01-01)
by: Jin-A Mo, et al.
Published: (2015-01-01)
Preclinical evidence and possible mechanisms of β-asarone for rats and mice with Alzheimer’s disease: A systematic review and meta-analysis
by: Xin-Yuan Du, et al.
Published: (2022-08-01)
by: Xin-Yuan Du, et al.
Published: (2022-08-01)
Effect of berberine on cognitive function and β-amyloid precursor protein in Alzheimer’s disease models: a systematic review and meta-analysis
by: Jia-Yang Liu, et al.
Published: (2024-01-01)
by: Jia-Yang Liu, et al.
Published: (2024-01-01)
Locus coeruleus in the pathogenesis of Alzheimer's disease: A systematic review
by: Yuqing Chen, et al.
Published: (2022-01-01)
by: Yuqing Chen, et al.
Published: (2022-01-01)
Risk factors for the alzheimer's disease. Systematic review and meta-analysis
by: G. R. Khasanova, et al.
Published: (2024-01-01)
by: G. R. Khasanova, et al.
Published: (2024-01-01)
Comparison of effects of different dietary interventions on cognitive function in Alzheimer’s disease: protocol for systematic review and network meta-analysis
by: Hong Li, et al.
Published: (2021-01-01)
by: Hong Li, et al.
Published: (2021-01-01)
Pediatric Tui Na for Feeding Intolerance in Premature Infants: Protocol for a Systematic Review and Meta-Analysis
by: Zirong Bai, et al.
Published: (2023-10-01)
by: Zirong Bai, et al.
Published: (2023-10-01)
Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis.
by: Shinji Matsunaga, et al.
Published: (2015-01-01)
by: Shinji Matsunaga, et al.
Published: (2015-01-01)
Cognitive effects of dopaminergic treatment in Alzheimer's disease: Systematic review and meta‐analysis
by: Cristina Bonet Olivares, et al.
Published: (2025-07-01)
by: Cristina Bonet Olivares, et al.
Published: (2025-07-01)
Efficacy and safety of chinese herbal medicines combined with chemical drugs for alzheimer's disease: A systematic review and meta-analysis
by: Li Xu, et al.
Published: (2024-01-01)
by: Li Xu, et al.
Published: (2024-01-01)
Epidemiology and risk factors of Alzheimer’s disease and related dementias in South and Southeast Asia: a systematic review and meta-analysis protocol
by: Zhahirul Islam, et al.
Published: (2025-08-01)
by: Zhahirul Islam, et al.
Published: (2025-08-01)
Polygala tenuifolia and Acorus tatarinowii in the treatment of Alzheimer’s disease: a systematic review and meta-analysis
by: Yuchen Zhang, et al.
Published: (2024-01-01)
by: Yuchen Zhang, et al.
Published: (2024-01-01)
The role of genetic polymorphisms on drug response in Alzheimer’s disease: a systematic review
by: Fresthel Monica M. Climacosa, et al.
Published: (2025-10-01)
by: Fresthel Monica M. Climacosa, et al.
Published: (2025-10-01)
A review of β-amyloid neuroimaging in Alzheimer’s disease
by: Paul eAdlard, et al.
Published: (2014-10-01)
by: Paul eAdlard, et al.
Published: (2014-10-01)
The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials
by: Wenxue Wu, et al.
Published: (2023-11-01)
by: Wenxue Wu, et al.
Published: (2023-11-01)
Amyloid-β Peptide-targeting Immunotherapy in Alzheimer Disease: A Systematic Review of Clinical Studies
by: Haideh Mosleh, et al.
Published: (2024-10-01)
by: Haideh Mosleh, et al.
Published: (2024-10-01)
The role of PrPc in Alzheimer's disease related Amyloid-β hypothesis: a systematic review
by: Tomás Andrade Magalhães Gomes, et al.
Published: (2023-09-01)
by: Tomás Andrade Magalhães Gomes, et al.
Published: (2023-09-01)
Prevalence and correlation of sarcopenia with Alzheimer's disease: A systematic review and meta-analysis.
by: Chen Su, et al.
Published: (2025-01-01)
by: Chen Su, et al.
Published: (2025-01-01)
Apolipoprotein E and Alzheimer’s Disease in Italian Population: Systematic Review and Meta-Analysis
by: Diana Marisol Abrego-Guandique, et al.
Published: (2024-09-01)
by: Diana Marisol Abrego-Guandique, et al.
Published: (2024-09-01)
Lipid level and risk of Alzheimer′s disease: a systematic review and meta-analysis
by: Xuan-rui LÜ, et al.
Published: (2022-08-01)
by: Xuan-rui LÜ, et al.
Published: (2022-08-01)
Neutrophil to lymphocyte ratio in Alzheimer’s disease: A systematic review and meta-analysis
by: Aynaz Mohammadi, et al.
Published: (2024-01-01)
by: Aynaz Mohammadi, et al.
Published: (2024-01-01)
Neutrophil to lymphocyte ratio in Alzheimer's disease: A systematic review and meta-analysis.
by: Aynaz Mohammadi, et al.
Published: (2024-01-01)
by: Aynaz Mohammadi, et al.
Published: (2024-01-01)
Stem Cell Therapy for Alzheimer’s Disease: A Scoping Review for 2017–2022
by: Yunxiao Duan, et al.
Published: (2023-01-01)
by: Yunxiao Duan, et al.
Published: (2023-01-01)
Association between choline supplementation and Alzheimer’s disease risk: a systematic review protocol
by: Sixtus Aguree, et al.
Published: (2023-08-01)
by: Sixtus Aguree, et al.
Published: (2023-08-01)
Critical assessment of anti-amyloid-β monoclonal antibodies effects in Alzheimer’s disease: a systematic review and meta-analysis highlighting target engagement and clinical meaningfulness
by: Konstantinos I. Avgerinos, et al.
Published: (2024-10-01)
by: Konstantinos I. Avgerinos, et al.
Published: (2024-10-01)
Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer’s disease and dementia
by: Matilde Nerattini, et al.
Published: (2023-10-01)
by: Matilde Nerattini, et al.
Published: (2023-10-01)
Similar Items
-
Resting-state functional reorganisation in Alzheimer’s disease and amnestic mild cognitive impairment: protocol for a systematic review and meta-analysis
by: Diyang Lyu, et al.
Published: (2021-10-01) -
Antiamyloid therapies for Alzheimer's disease: an experts' dialogue on facts and controversies
by: Paulo Caramelli
Published: (2025-05-01) -
The Comparative Efficacy of Anti-Amyloid and Non-Antiamyloid Drugs for Treatment of Alzheimer’s Disease: A Network Meta-Analysis
by: Norah Htet Htet, et al.
Published: (2023-12-01) -
Clinical Benefits and Risks of Antiamyloid Antibodies in Sporadic Alzheimer Disease: Systematic Review and Network Meta-Analysis With a Web Application
by: Danko Jeremic, et al.
Published: (2025-04-01) -
Dendrimers as Antiamyloid Agents
by: Svetlana A. Sorokina, et al.
Published: (2022-03-01)
